Acute coronary syndrome in older populations: integrating evidence into clinical practice

Abstract

Acute coronary syndrome (ACS) disproportionately affects older populations. This is despite advancements in diagnosis and management over the past few decades leading to an overall improvement in clinical outcomes in patients with ACS. Patients aged ≥ 70 years account for more than one third of all patients admitted to hospital with ACS and are at the highest risk of complications including mortality. This article reviews ACS in older populations, including the epidemiology, changes in physiology contributing to increased risk, clinical manifestations, inadequacy of current diagnostic methods, and controversies around recommended management strategies.

Keywords

Myocardial infarction / aging / clinical manifestation / diagnosis / treatment / older

References

[1] Virani SS,Aparicio HJ.American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics-2021 update: a report from the American heart association.Circulation2021;143:e254-743

[2] Roger VL.Epidemiology of myocardial infarction.Med Clin North Am2007;91:537-52; ix PMCID:PMC2537993

[3] Kochar A,Sharma PP.Long-term mortality of older patients with acute myocardial infarction treated in US clinical practice.J Am Heart Assoc2018;7:e007230 PMCID:PMC6064921

[4] Ha NT,Moorin R.Impact of population ageing on the costs of hospitalisations for cardiovascular disease: a population-based data linkage study.BMC Health Serv Res2014;14:554 PMCID:PMC4236486

[5] Benjamin EJ,Alonso A.American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics-2019 update: a report from the American heart association.Circulation2019;139:e56-e528

[6] Rodgers JL,Bolleddu SI.Cardiovascular risks associated with gender and aging.J Cardiovasc Dev Dis2019;6:19 PMCID:PMC6616540

[7] Arnold AM,Kuller LH.Incidence of cardiovascular disease in older Americans: the cardiovascular health study.J Am Geriatr Soc2005;53:211-8

[8] Dai X,Alexander KP.Acute coronary syndrome in the older adults.J Geriatr Cardiol2016;13:101-8 PMCID:PMC4854946

[9] Avezum A,Spencer F.GRACE InvestigatorsImpact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).Am Heart J2005;149:67-73

[10] Bonetti PO,Lerman A.Endothelial dysfunction: a marker of atherosclerotic risk.Arterioscler Thromb Vasc Biol2003;23:168-75

[11] Gerhard M,Creager SJ.Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans.Hypertension1996;27:849-53

[12] Muller-Delp JM,Ramsey MW.Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles.Am J Physiol Heart Circ Physiol2002;283:H1662-72

[13] Taddei S,Ghiadoni L.Age-related reduction of NO availability and oxidative stress in humans.Hypertension2001;38:274-9

[14] Gryglewski RJ,Moncada S.Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.Nature1986;320:454-6

[15] Rush JW.Nitric oxide, oxidative stress and vascular endothelium in health and hypertension.Clin Hemorheol Microcirc2007;37:185-92

[16] van Geemen D,Oomen PJ.Age-dependent changes in geometry, tissue composition and mechanical properties of fetal to adult cryopreserved human heart valves.PLoS One2016;11:e0149020 PMCID:PMC4750936

[17] Westaby S,Blackstone EH.Adult human valve dimensions and their surgical significance.Am J Cardiol1984;53:552-6

[18] Schenk KE.Age-dependent changes of heart valves and heart size.Recent Adv Stud Cardiac Struct Metab1975;10:617-24

[19] Olivetti G,Capasso JM.Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy.Circ Res1991;68:1560-8

[20] Behar J.Age-related pacemaker deterioration is due to impaired intracellular and membrane mechanisms: insights from numerical modeling.J Gen Physiol2017;149:935-49 PMCID:PMC5694941

[21] Fleg JL,Wright J.Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers.J Gerontol1990;45:M95-100

[22] Kurachi K.Genetic mechanisms of age regulation of blood coagulation: factor IX model.Arterioscler Thromb Vasc Biol2000;20:902-6

[23] Kurachi S,Takeshita J.Genetic mechanisms of age regulation of human blood coagulation factor IX.Science1999;285:739-43

[24] Sweeney JD.Age-dependent effect on the level of factor IX.Am J Clin Pathol1993;99:687-8

[25] Amin H,Aslam M.Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population.Blood Coagul Fibrinolysis2012;23:745-50

[26] Mari D,Castaldi D,Bollini EM.Hemostasis and ageing.Immun Ageing2008;5:12 PMCID:PMC2602988

[27] Ferrucci L.Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.Nat Rev Cardiol2018;15:505-22 PMCID:PMC6146930

[28] DelaRosa O,Peralbo E.Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity.Biogerontology2006;7:471-81

[29] Wikby A,Forsey R.The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning.Mech Ageing Dev2006;127:695-704

[30] Varadhan R,Matteini A.Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults.J Gerontol A Biol Sci Med Sci2014;69:165-73 PMCID:PMC4038244

[31] Li DB,Liu Z,Xu LQ.Association between inflammatory mediators and angiographic morphologic features indicating thrombus formation in patients with acute myocardial infarction.Chin Med J (Engl)2009;122:1738-42

[32] Jones CI.Platelet function and ageing.Mamm Genome2016;27:358-66 PMCID:PMC4935731

[33] Balduini CL.Platelet count and aging.Haematologica2014;99:953-5 PMCID:PMC4040891

[34] Mohebali D,Carlisle M,Rondina MT.Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults.J Am Geriatr Soc2014;62:529-35 PMCID:PMC3959242

[35] Nadlacki B,Hossain S.Long term survival after acute myocardial infarction in Australia and New Zealand, 2009-2015: a population cohort study.Med J Aust2021;214:519-25

[36] Noble JM,Ford GA.Effect of age on plasma membrane asymmetry and membrane fluidity in human leukocytes and platelets.J Gerontol A Biol Sci Med Sci1999;54:M601-6

[37] Vlasic N,Schwarz SM,Stemerman MB.Lipid fluidity modulates platelet aggregation and agglutination.Life Sciences1993;53:1053-60

[38] Watala C,Boncler MA,Gwoździński K.Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood.Platelets1998;9:315-27

[39] Zahavi J,Al-hasani S.Enhanced in-vivo platelet release reaction, increased thromboxane synthesis, and decreased prostacyclin release after tourniquet ischaemia.Lancet1980;316:663-7

[40] Bastyr EJ,Vinik AI.Platelet activity and phosphoinositide turnover increase with advancing age.Am J Med1990;88:601-6

[41] Wagner DD.Platelets in inflammation and thrombosis.Arterioscler Thromb Vasc Biol2003;23:2131-7

[42] Goch A,Rysz J.The clinical manifestation of myocardial infarction in elderly patients.Clin Cardiol2009;32:E46-51 PMCID:PMC6653078

[43] Wroblewski M,Steen B.Symptoms of myocardial infarction in old age: clinical case, retrospective and prospective studies.Age Ageing1986;15:99-104

[44] RODSTEIN M.The characteristics of nonfatal myocardial infarction in the aged.AMA Arch Intern Med1956;98:84-90

[45] Pathy MS.Clinical presentation of myocardial infarction in the elderly.Br Heart J1967;29:190-9 PMCID:PMC459132

[46] Bayer AJ,Farag RR.Changing presentation of myocardial infarction with increasing old age.J Am Geriatr Soc1986;34:263-6

[47] Malik MA,Safdar S.Chest Pain as a presenting complaint in patients with acute myocardial infarction (AMI).Pak J Med Sci2013;29:565-8 PMCID:PMC3809224

[48] Ochiai ME,Buzo CG.Atypical manifestation of myocardial ischemia in the elderly.Arq Bras Cardiol2014;102:e31-3 PMCID:PMC3987323

[49] Rittger H,Breithardt OA.Influence of age on pain perception in acute myocardial ischemia: a possible cause for delayed treatment in elderly patients.Int J Cardiol2011;149:63-7

[50] Aronow WS.Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients.Am J Cardiol1987;60:1182

[51] Mittelmark MB,Rautaharju PM.Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study.Am J Epidemiol1993;137:311-7

[52] Jolobe OM.Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study.Eur Heart J2006;27:1383-4

[53] Melgarejo-moreno A,García-alberola A,González-sánchez A.Clinical and prognostic characteristics associated with age and gender in acute myocardial infarction: a multihospital perspective in the Murcia region of Spain.Eur J Epidemiol1999;15:621-9

[54] Solomon CG,Cook E.Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the multicenter chest pain study experience.Am J Cardiol1989;63:772-6

[55] Bagai A,Udell JA.Association of cognitive impairment with treatment and outcomes in older myocardial infarction patients: a report from the NCDR Chest Pain-MI registry.J Am Heart Assoc2019;8:e012929 PMCID:PMC6755847

[56] Leonardi S,Ahrens I,Bonnefoy E.Optimised care of elderly patients with acute coronary syndrome.Eur Heart J Acute Cardiovasc Care2018;7:287-95

[57] Han JH.Altered mental status in older patients in the emergency department.Clin Geriatr Med2013;29:101-36 PMCID:PMC3614410

[58] Auer R,Marques-Vidal P.Health ABC StudyAssociation of major and minor ECG abnormalities with coronary heart disease events.JAMA2012;307:1497-505 PMCID:PMC4006989

[59] Rogers WJ,Chandra NC.Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the national registry of myocardial infarction.Circulation1994;90:2103-14

[60] Rogers WJ,Lambrew CT.Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999.J Am Coll Cardiol2000;36:2056-63

[61] Hammarsten O,Sigurjonsdottir R.Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction.Clin Chem2012;58:628-37

[62] Koerbin G,Hickman PE.Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population.Ann Clin Biochem2010;47:524-8

[63] Latini R,Anand IS.Val-HeFT InvestigatorsPrognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.Circulation2007;116:1242-9

[64] Arshed S,Zafar S.Elevated troponin I in the absence of coronary artery disease: a case report with review of literature.J Clin Med Res2015;7:820-4 PMCID:PMC4554225

[65] Rayner HC,Bommer J.Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Nephrol Dial Transplant2004;19:108-20

[66] Mehta NJ,Khan IA.Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism.Am Heart J2003;145:821-5

[67] Baillard C,Fosse JP.Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease.Intensive Care Med2003;29:584-9

[68] Tegn N,Aaberge L.Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.Lancet2016;387:1057-65

[69] Buber J,Kimron L.One-year outcome following coronary angiography in elderly patients with non-ST elevation myocardial infarction: real-world data from the Acute Coronary Syndromes Israeli Survey (ACSIS).Coron Artery Dis2013;24:102-9

[70] Rajani R LM DG.Evolving trends in percutaneous coronary intervention.Br J Cardiol2011;18:73-6

[71] Kurotobi T,Kinjo K.OACIS GroupReduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction.J Am Coll Cardiol2004;44:28-34

[72] Lee PY,Hammill BG,Peterson ED.Representation of elderly persons and women in published randomized trials of acute coronary syndromes.JAMA2001;286:708-13

[73] Damluji AA,van Diepen S.American Heart Association Council on Clinical Cardiology and Council on Cardiovascular and Stroke NursingOlder adults in the cardiac intensive care unit: factoring geriatric syndromes in the management, prognosis, and process of care: a scientific statement from the American heart association.Circulation2020;141:e6-e32

[74] Afilalo J.Frailty in patients with cardiovascular disease: why, when, and how to measure.Curr Cardiovasc Risk Rep2011;5:467-72 PMCID:PMC3165117

[75] Bell CM,Gunraj N.Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases.JAMA2011;306:840-7

[76] Garpestad E.Polypharmacy and delirium in critically ill older adults: recognition and prevention.Clin Geriatr Med2017;33:189-203

[77] Tosato M,Martone AM.Investigators of the CRIME StudyPotentially inappropriate drug use among hospitalised older adults: results from the CRIME study.Age Ageing2014;43:767-73

[78] Mittel A.Supporting the geriatric critical care patient: decision making, understanding outcomes, and the role of palliative care.Anesthesiol Clin2019;37:537-46 PMCID:PMC6719536

[79] Ibanez B,Agewall S.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Kardiol Pol2018;76:229-313

[80] Gawaz M.Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.Cardiovasc Res2004;61:498-511

[81] Li S,Hamilton JR.Using PAR4 inhibition as an anti-thrombotic approach: why, how, and when?.Int J Mol Sci2019;20:5629 PMCID:PMC6888008

[82] Ornelas A,Menter DG.Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.Cancer Metastasis Rev2017;36:289-303 PMCID:PMC5557878

[83] Wickramarachchi U,Eccleshall S. Drug-coated balloons in STEMI. In: Watson TJ, Ong PJL, Tcheng JE, editors. Primary Angioplasty: a Practical Guide. Singapore 2018. p. 151-65.

[84] Goldstein RE,Hall WJ.Marked reduction in long-term cardiac deaths with aspirin after a coronary event.J Am Coll Cardiol1996;28:326-30

[85] Aronow WS.Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins.Heart Dis2002;4:159-61

[86] Mauri L,Yeh RW.DAPT Study InvestigatorsTwelve or 30 months of dual antiplatelet therapy after drug-eluting stents.N Engl J Med2014;371:2155-66 PMCID:PMC4481318

[87] Mehta SR,Peters RJ.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.Lancet2001;358:527-33

[88] Husted S,Becker RC.PLATO study groupTicagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial.Circ Cardiovasc Qual Outcomes2012;5:680-8

[89] Lindholm D,Cannon CP.Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.Eur Heart J2014;35:2083-93 PMCID:PMC4132637

[90] Szummer K,Alfredsson J.Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: insights from the SWEDEHEART registry.Circulation2020;142:1700-8

[91] Ferreiro JL,Angiolillo DJ.Cangrelor: a review on its mechanism of action and clinical development.Expert Rev Cardiovasc Ther2009;7:1195-201

[92] Cavender MA,Stone GW.CHAMPION PHOENIX Investigators*Cangrelor in older patients undergoing percutaneous coronary intervention: findings from CHAMPION PHOENIX.Circ Cardiovasc Interv2017;10:e005257

[93] Wiviott SD,McCabe CH.TRITON-TIMI 38 InvestigatorsPrasugrel versus clopidogrel in patients with acute coronary syndromes.N Engl J Med2007;357:2001-15

[94] Savonitto S,Piatti L.Elderly ACS 2 InvestigatorsComparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization.Circulation2018;137:2435-45

[95] Bhatt DL.Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.JAMA2000;284:1549-58

[96] Guagliumi G,Cox DA.Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.Circulation2004;110:1598-604

[97] Amsterdam EA,Brindis RG.2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American college of cardiology/American heart association task force on practice guidelines.J Am Coll Cardiol2014;64:e139-228

[98] Steg PG,Mehta SR.FUTURA/OASIS-8 Trial GroupLow-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.JAMA2010;304:1339-49

[99] a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.Lancet1990;336:65-71

[100] Garcia DA,Weitz JI.Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines.Chest2012;141:e24S-43S PMCID:PMC3278070

[101] Montalescot G,Silvain J.Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.Lancet2011;378:693-703

[102] Puymirat E,Collet JP.Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registry.Int J Cardiol2013;166:106-10

[103] Claessen BE,Gibson CM.Lipid management in patients presenting with acute coronary syndromes: a review.J Am Heart Assoc2020;9:e018897 PMCID:PMC7955383

[104] Afilalo J,Steele R,de Craen AJ.Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.J Am Coll Cardiol2008;51:37-45

[105] Catapano AL,De Backer G.2016 ESC/EAS guidelines for the management of dyslipidaemias.Kardiol Pol2016;74:1234-318

[106] Ko DT,Alter DA.Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.JAMA2004;291:1864-70

[107] Fonarow GC,Parsons LS,Malmgren JA.Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.Circulation2001;103:38-44

[108] Mitchell S,Samuel M.Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies.BMC Cardiovasc Disord2016;16:74 PMCID:PMC4845323

[109] Miettinen TA,Olsson AG.Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).Circulation1997;96:4211-8

[110] effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.Lancet1994;343:1115-22

[111] Pfeffer MA,Moyé LA.Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.N Engl J Med1992;327:669-77

[112] Gianni M,Pogue J.Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.Eur Heart J2007;28:1382-8

[113] trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.Lancet1986;2:57-66

[114] intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial.Lancet2005;366:1622-32

[115] Norris R,Clarke E.Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol.Lancet1984;324:883-6

[116] Roberts R,Mueller HS.Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.Circulation1991;83:422-37

[117] Pepine CJ,Deedwania PC.Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST).Circulation1994;90:762-8

[118] Antman EM,Armstrong PW.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).J Am Coll Cardiol2004;44:E1-E211

[119] Tarkin JM.Vasodilator therapy: nitrates and nicorandil.Cardiovasc Drugs Ther2016;30:367-78 PMCID:PMC5658472

[120] Miller MR.Understanding organic nitrates--a vein hope?.Br J Pharmacol2009;157:565-7 PMCID:PMC2707969

[121] The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine.European Study of Prevention of Infarct with Molsidomine (ESPRIM) Group.Lancet1994;344(8915):91-7

[122] a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.Lancet1995;345:669-85

[123] Roffi M,Collet JP.2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).G Ital Cardiol (Rome)2016;17:831-72

[124] Newell MC,Henry TD.Impact of age on treatment and outcomes in ST-elevation myocardial infarction.Am Heart J2011;161:664-72

[125] Bueno H,Heras M.TRIANA InvestigatorsPrimary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies.Eur Heart J2011;32:51-60 PMCID:PMC3013200

[126] Kaura A,Trickey A.Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data.Lancet2020;396:623-34 PMCID:PMC7456783

[127] Shanmugasundaram M.Percutaneous coronary intervention in elderly patients: is it beneficial?.Tex Heart Inst J2011;38:398-403 PMCID:PMC3147189

[128] Damman P,Wallentin L.Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.Heart2012;98:207-13

[129] McCullough PA,Dibattiste PM.TACTICS-TIMI-18 InvestigatorsTiming of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial.J Interv Cardiol2004;17:81-6

[130] Gnanenthiran SR,D'Souza M,Brieger DB.Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.Heart2017;103:1962-9

[131] CDC. Interactive Atlas of Heart Disease and Stroke 2019. Available from: https://nccd.cdc.gov/DHDSPAtlas/Reports.aspx [Last accessed on 9 Aug 2022]

[132] Savonitto S,Petronio AS.Italian Elderly ACS Trial InvestigatorsEarly aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.JACC Cardiovasc Interv2012;5:906-16